metabolic licenses aod9604 to australian custo

  1. 20,536 Posts.
    lightbulb Created with Sketch. 1835

    http://www.asx.com.au/asxpdf/20140128/pdf/42mb0qs0v2bzxx.pdf

    Calzada Limited (ASX:CZD) is pleased to report that its fully owned subsidiary,Metabolic Pharmaceuticals Pty
    Ltd (Metabolic),has entered into a non - exclusive
    license with Australian Custom Pharmaceuticals, Australia’s
    largest compounding pharmacy , based in Taren Point,Sydney, NSW.

    This licence is solely for the use, manufacture and sale of
    AOD9604 in compounded medicine preparations that comply with all Australian regulatory requirements
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.